No Detail Found!

Impact of Growth Hormone Co-Treatment in Patients with Diminished Ovarian Reserve on In-Vitro Fertilisation Outcomes

Author(s)
Pinar Karacin Department of Gynaecology, Etlik Zubeyde Hanim Training and Research Hospital,Ankara,Turkiye
Runa Ozelci Department of Gynaecology, Etlik Zubeyde Hanim Training and Research Hospital,Ankara,Turkiye
Enes Kumcu Department of Gynaecology, Etlik City Hospital,Ankara,Turkiye
Dilek Kaya kaplanoglu Department of Gynaecology, Adana Yuregir State Hospital,Adana,Turkiye
Serdar Dilbaz Department of Gynaecology, Etlik City Hospital,Ankara,Turkiye
Yaprak Ustun Department of Gynaecology, Etlik City Hospital,Ankara,Turkiye
Abstract
Objective: To assess the e cacy of growth hormone (GH) co-treatment during controlled ovarian stimulation for in-vitro fertilisation (IVF). Study Design: Descriptive analytical. Place and Duration of the Study: Department of Gynaecology, Etlik Zubeyde Hanim Training and Research Hospital, Ankara, Turkiye, from January 2010 to 2023. Methodology: A total of 191 women with diminished ovarian reserve (DOR) who underwent IVF cycles were included in the study. Eightynine patients with DOR who received GH during the study period were designated as the study group (Group A), and the 102 patients with DOR who did not receive GH were chosen as the control group (Group B). Chi-square and Mann-Whitney U tests were used to compare groups variables. Results: The Group B's basal estradiol and FSH levels were higher than those of Group A. No signi cant correlation was found in regards to number of 2PNs (pro-nuclear), and the count of collected oocytes. The clinical pregnancy rate of the groups was comparable [(n = 13 (27.7%) vs. n = 19 (35.2%), p = 0.417)]. Conclusion: This study has shown that the clinical pregnancy rate did not increase signi cantly in the GH group.
Publication Details
Page(s) 278-281
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 35, Issue: 3, Year: 2025

Request the full text from PASTIC

Keywords
Growth hormone, clinical pregnancy rate, Controlled ovarian hyperstimulation, In-vitro fertilisation
References
Mahabbat NA,Khan TA,Elyas MF,Mahabbat AA,Oraif AM .2024 .Role of in-vitro fertilization (IVF) in unexplained infertility management: A systematic review. Cureus, 10(10) : .
Jiang VS,Bormann CL .2023 .Arti cial intelligence in the in vitro fertilization laboratory: A review of advancements over the last decade. Fertil Steril, 05(1) : 17-23.
Eller ABP,Ejzenberg D,Monteleone PAA,Soares JM .2023 .Vitamin D and in-vitro fertilization: A systematic review. J Assist Reprod Genet, 10(4) : 735-43.
Kaleli S,Kervancioglu ME,Erol N,Alakbarova U,Aksahin E,Ocer IF .2023 .Evaluating the e cacy of ovulation stimulation with intrauterine insemination in women with diminished ovarian reserve compared to women with normal ovarian reserve. Int J Gynecol Obst, 10(2) : 620-7.
Hosseinzadeh P,Wild RA,Hansen KR .2023 .Diminished ovarian reserve: Risk for preeclampsia in in-vitro fertilization pregnancies. Fertil Steril, 03(5) : 802-3.
Wang ZY,Huang SX,Yang JD,Li DP,Xu YW .2023 .Subfertile Chinese patients with diminished ovarian reserve: An analysis of pregnancy outcomes of ART cycles. Pak J Med Sci, 10(2) : 338-43.
Zhu Q,Li Y,Ma J,Ma H,Liang X .2023 .Potential factors result in diminished ovarian reserve: A comprehensive review. J Ovarian Res, 10(1) : 208.
Li S,Hu L,Zhang C. .2021 .E ect of chronological age of patients with diminished ovarian reserve onin-vitro fertilization outcome. J Obstet Gynaecol, 1922996(4) : 654-7.
Dakhly DM,Bassiouny YA,Bayoumi YA,Hassan MA,Gouda HM,Hassan AA .2018 .The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in-vitro fertilization: randomized control trial. Eur J Obstet Gynecol Reprod Biol, 06 : 161-5.
Bassiouny YA,Dakhly DMR,Bayoumi YA,Hashish NM .2015 .Does the addition of growth hormone to the in-vitro fertilization/intracytoplasmic sperm injection antagonist protocol improve outcomes in poor responders? A randomized, controlled trial. Fertil Steril, 11(3) : 697-702.
Lattes K,Brassesco M,Gomez M,Checa MA . .Low-dose growth hormone supplementation increases clinical pregnancy rate in poor responders undergoing in-vitro fertilisa-. , : .
Eftekhar M,A atoonian A,Mohammadian F,Eftekhar T. .2013 .Adjuvant growth hormone therapy in antagonist protocol in poor responders undergoing assisted reproductive technology. Arch Gynecol Obstet, 10(5) : 1017-21.
.2023 .. J Reprod Infertil, 10(4) : 279-86.
. .. , : 14155.
Kyrou D,Kolibianakis EM,Venetis CA,Papanikolaou EG,Bontis J,Tarlatzis BC .2007 .How to improve the probability of pregnancy in poor responders undergoing in-vitro fertilization: A systematic review and meta-analysis. Fertil Steril, 12(3) : 749-66.
Ho YK,Lee TH,Lee CI,Cheng EH,Huang CC,Huang LS,Kucuk T,Kozinoglu H,Kaba A .2017 .Growth hormone co-treatcontrolled ovarian stimulation in infertile women of ment within a GnRH agonist long protocol in patients with advanced age, poor responders, and previous in-vitro fertil- poor ovarian response: A prospective, randomized, clinical ization failure patients. Taiwan J Obstet Gynecol2017; trial. J Assist Reprod Genet, 10(6) : 806-10.
Hart RJ,Rombauts L,Norman RJ .2017 .Growth hormone in IVF cycles: Any hope. Curr Opin Obstet Gynecol, 10(3) : 119-25.
Mohammadshirazi Z,Alyasin A,Hosseini MA,Hazari V.,Ipsa E,Cruzat VF,Kagize JN,Yovich JL,Keane KN .2019 .Growth hormone and insulin-like growth factor action in reproductive tissues. Front Endocrinol (Lausanne), 00777 : 777.
0

Citations

0

Downloads

57

Views